Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Ahlin Grabnar, Pegi"'
Publikováno v:
In International Journal of Pharmaceutics 25 December 2024 667 Part A
Autor:
Prašnikar, Monika, Proj, Matic, Bjelošević Žiberna, Maja, Lebar, Blaž, Knez, Benjamin, Kržišnik, Nika, Roškar, Robert, Gobec, Stanislav, Grabnar, Iztok, Žula, Aleš, Ahlin Grabnar, Pegi
Publikováno v:
In International Journal of Pharmaceutics 25 April 2024 655
Autor:
Mitrović, Jelena R., Bjelošević Žiberna, Maja, Vukadinović, Aleksandar, Knutson, Daniel E., Sharmin, Dishary, Kremenović, Aleksandar, Ahlin Grabnar, Pegi, Planinšek, Odon, Lunter, Dominique, Cook, James M., Savić, Miroslav M., Savić, Snežana D.
Publikováno v:
In European Journal of Pharmaceutical Sciences 1 October 2023 189
Publikováno v:
In Journal of Drug Delivery Science and Technology April 2023 82
Autor:
Bjelošević Žiberna, Maja1 (AUTHOR) maja.bjelosevic.ziberna@ffa.uni-lj.si, Ahlin Grabnar, Pegi1 (AUTHOR) pegi.ahlingrabnar@ffa.uni-lj.si
Publikováno v:
Pharmaceutics. Jul2023, Vol. 15 Issue 7, p1967. 16p.
Autor:
Bjelošević, Maja, Ahlin Grabnar, Pegi
Publikováno v:
In Journal of Drug Delivery Science and Technology June 2021 63
Publikováno v:
In International Journal of Pharmaceutics 5 July 2015 488(1-2):127-135
Publikováno v:
In European Journal of Pharmaceutical Sciences 27 September 2013 50(1):93-101
Autor:
Mitrović, Jelena, Bjelošević, Maja, Knutson, Daniel E., Kremenović, Aleksandar, Lunter, Dominique, Ahlin Grabnar, Pegi, Cook, James M., Savić, Miroslav, Savić, Snežana
Publikováno v:
9th BBBB International conference on pharmaceutical sciences; 15th-17th September, Ljubljana, Slovenia
1. INTRODUCTION Nanocrystal dispersions are considered as the universal formulation strategy for brick dust substances. However, the stability of these systems to aggregation represents a big issue. To overcome this, nanocrystal dispersions are usual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4877::cfda6beb1b2f03c276e3d717214b7f10
https://hdl.handle.net/21.15107/rcub_farfar_4270
https://hdl.handle.net/21.15107/rcub_farfar_4270
Autor:
Mitrović, Jelena, Bjelošević, Maja, Đoković, Jelena, Ahlin Grabnar, Pegi, Planinšek, Odon, Knutson, Daniel, Cook, James, Savić, Miroslav, Savić, Snežana
Despite of good pharmacodynamics of DK-I-56-1, novel deuterated pyrazoloquinolinones ligand, low solubility limits its administration. Nanosuspensions can help to overcome this problem, but its small particle size usually leads to particle agglomerat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4877::c72a14916f0f4632e449025e88161eb9
https://hdl.handle.net/21.15107/rcub_farfar_3744
https://hdl.handle.net/21.15107/rcub_farfar_3744